Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$781,090
+$175,163 QoQ
Shares Held
3,104
+11.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,785
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Colonial Trust Advisors holds $80,602,138 across 14 Drug Manufacturers - General names. ABBV ranks #5 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,773 | $42,907,212 | |
| 2 | JNJ |
Johnson & Johnson
|
134,256 | $34,096,996 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,658 | $1,112,553 | |
| 4 | AMGN |
Amgen Inc
|
2,503 | $906,386 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
3,104 | $781,090 | |
| 6 | NVS |
Novartis AG
|
1,390 | $217,840 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,467 | $199,768 | |
| 8 | NVO |
Novo Nordisk A S
|
3,581 | $171,673 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $781,090 | 3,104 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $605,927 | 2,786 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $660,793 | 2,892 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $650,395 | 2,809 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $547,022 | 2,947 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $571,361 | 2,727 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $460,243 | 2,590 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $539,712 | 2,733 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $467,735 | 2,727 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $531,549 | 2,919 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $440,734 | 2,844 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $423,926 | 2,844 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $383,711 | 2,848 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $453,885 | 2,848 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $461,719 | 2,857 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $383,437 | 2,857 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $321,176 | 2,097 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $339,944 | 2,097 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $280,142 | 2,069 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $223,183 | 2,069 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $233,052 | 2,069 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $234,729 | 2,169 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $233,158 | 2,176 | Shares | Sole | 2021-01-29 | |
| No filing history on record for this holder in this stock. | ||||||